MAGEC3 and esophageal squamous cell carcinoma: highlighted that elevated MAGE‐C3 expression in ESCC facilitates EMT and immune evasion, enhancing metastasis, and suggesting MAGE‐C3 as a prognostic marker and therapeutic target.